Why (oh why) did I ever buy these shares?Oh I remember! Those wildly inaccurate share market statics in a highly reputable financial publication which I've already had a moan about on an earlier post.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
